NCT02496715View on ClinicalTrials.gov

Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate 100 mcg / salmeterol 50 mcg

Brand inhaler containing pMDI containing fluticasone and salmeterol

DRUG

Generic fluticasone propionate 100 mcg / salmeterol 50 mcg

Generic inhaler containing pMDI containing fluticasone and salmeterol

DRUG

Placebo

Placebo inhaler

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT02496715 - Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics | Biotech Hunter | Biotech Hunter